No abstract available
MeSH terms
-
Aged
-
Anemia, Aplastic / complications
-
Cancer Vaccines*
-
Clinical Trials, Phase I as Topic
-
Drug Resistance, Neoplasm
-
Female
-
Humans
-
Injections, Subcutaneous
-
Leukemia, Myeloid, Acute / drug therapy*
-
Leukemia, Myeloid, Acute / immunology
-
Leukemia, Myeloid, Acute / physiopathology
-
Male
-
Middle Aged
-
Myelodysplastic Syndromes / drug therapy*
-
Myelodysplastic Syndromes / etiology
-
Myelodysplastic Syndromes / immunology
-
Oligopeptides / administration & dosage*
-
Oligopeptides / adverse effects
-
Peptides / administration & dosage*
-
Peptides / adverse effects
-
Recurrence
-
Remission Induction
-
Vaccination
-
WT1 Proteins / administration & dosage
-
WT1 Proteins / adverse effects
-
WT1 Proteins / chemistry
-
WT1 Proteins / genetics
-
WT1 Proteins / therapeutic use*
Substances
-
CMTWNQMNL peptide
-
Cancer Vaccines
-
Oligopeptides
-
Peptides
-
WT1 Proteins